Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$543K Sell
172,958
-8,539
-5% -$26.7K 0.02% 150
2026
Q1
$530K Hold
181,497
0.02% 152
2025
Q4
$448K Buy
+181,497
New +$432K 0.02% 157
2019
Q4
Sell
-32,496
Closed -$150K 274
2019
Q3
$150K Hold
32,496
0.01% 277
2019
Q2
$152K Hold
32,496
0.01% 284
2019
Q1
$140K Sell
32,496
-1,264
-4% -$5.81K 0.01% 277
2018
Q4
$132K Hold
33,760
0.01% 261
2018
Q3
$154K Buy
33,760
+285
+0.9% +$1.36K 0.01% 299
2018
Q2
$155K Sell
33,475
-58,007
-63% -$341K 0.01% 301
2018
Q1
$665K Buy
91,482
+1,363
+2% +$9.37K 0.06% 120
2017
Q4
$582K Buy
90,119
+189
+0.2% +$1.21K 0.06% 128
2017
Q3
$593K Buy
89,930
+13,400
+18% +$83K 0.06% 126
2017
Q2
$420K Buy
76,530
+405
+0.5% +$2.31K 0.04% 160
2017
Q1
$438K Sell
76,125
-7,698
-9% -$42.2K 0.05% 153
2016
Q4
$412K Hold
83,823
0.05% 157
2016
Q3
$510K Buy
83,823
+52,441
+167% +$313K 0.06% 121
2016
Q2
$185K Hold
31,382
0.02% 254
2016
Q1
$163K Buy
+31,382
New +$144K 0.02% 254

Other funds holding ABEV

Henshaw Capital's ABEV Position: Q2 2026 in Review

Henshaw Capital reduced its Ambev (ABEV) stake by 4.7% in Q2 2026, selling an estimated $26.7K and leaving 172,958 shares worth $543K. The position accounts for 0.02% of the portfolio, ranked #150.

Henshaw Capital first reported a position in ABEV in Q1 2016 and has held it in 18 quarters since. The position peaked at $665K in Q1 2018. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Henshaw Capital held 172,958 shares of Ambev worth $543K as of Q2 2026.
  • Henshaw Capital sold 8,539 Ambev shares in Q2 2026, an estimated $26.7K.
  • Ambev made up 0.02% of Henshaw Capital's portfolio in Q2 2026, its #150 holding.
  • Henshaw Capital first reported a position in Ambev in Q1 2016 and has held it in 18 quarters since.
  • Henshaw Capital's Ambev position peaked at $665K in Q1 2018.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Henshaw Capital's 13F filing for Q2 2026, filed 12 Aug 2026.